Medication info
Mepril Table (Glimepiride)

Mepril Table (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
IYun Pharmaceuticals Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200300131 · Notified 2003.06.14 · Insurance code 658600360

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
IYun Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications to enhance therapeutic effects. It helps effectively improve patients' blood sugar levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication is not to be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Patients with allergies to this drug, its components, or sulfonylurea drugs should not receive it. For patients with severe liver or kidney dysfunction, it is recommended to switch to insulin therapy instead of using this drug. Women who are pregnant or potentially pregnant and those who are breastfeeding should not take this medication. Patients with severe infections, those who are undergoing surgery, or those with severe trauma should be treated with insulin and need to exercise caution during gastrointestinal disturbances such as diarrhea or vomiting due to the risk of hypoglycemia. Additionally, this drug contains lactose, so patients with lactose intolerance or specific genetic metabolic disorders should not take it. During the initial week of treatment, the risk of hypoglycemia is high, and close monitoring is particularly necessary for the elderly, malnourished patients, those with irregular meals, and frequent alcohol consumers. Patients with weak kidney or liver function, those who have overdosed, and those with thyroid or adrenal dysfunction may also have an increased risk of hypoglycemia. When taking this medication with other drugs, it is essential to inform your doctor or pharmacist, as it may affect blood sugar control. The most common side effect while taking this medication is hypoglycemia, manifesting as headaches, severe hunger, nausea, fatigue, confusion, drowsiness, and, in severe cases, coma. If symptoms of hypoglycemia occur, sugar should be consumed immediately, and in severe cases, emergency treatment may be necessary. During initial dosing, temporary blurred vision or gastrointestinal symptoms (nausea, vomiting, abdominal pain, etc.) may occur. Abnormal liver function, blood disorders, and allergic reactions can also occur rarely, so immediate reporting to healthcare professionals is essential if unusual symptoms arise. When taking this medication, it should be taken regularly in conjunction with dietary and exercise therapies, and patients should always carry sugar to prevent hypoglycemia. In stressful situations, during surgery, or during infections, blood sugar control can become difficult, so consultation with healthcare professionals may lead to a switch to insulin therapy. Pregnant or breastfeeding women should not take this medication due to the potential effects on the fetus or newborn; insulin therapy should be considered if necessary. In case of an overdose, severe hypoglycemia may occur, requiring immediate emergency care, which may involve inducing vomiting, gastric lavage, or glucose injections. The safety and efficacy of this medication have not been established in children, and elderly patients may require dosage adjustments due to declining kidney function.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 67 more
  • decreased concentration
  • reduced agility or activity
  • depression
  • confusion
  • speech disturbances
  • aphasia
  • visual impairment
  • tremors
  • incomplete paralysis
  • sensory abnormalities
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • brain convulsions
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and moist skin
  • tachycardia
  • hypertension
  • palpitations
  • angina pectoris
  • venous dysrhythmia
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitive reactions of the skin
  • decreased serum sodium concentration
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. This ensures the medication's efficacy is safely preserved.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.